Limited proactive offering of video visits by oncology teams, especially for nonusers, reduced exposure and normalized ...
Sikander Ailawadhi, MD, of the Mayo Clinic Florida in Jacksonville, discusses the clinical significance and primary outcomes ...
In this episode of Community Corner, Christopher H. Lieu, MD, professor of medicine at the University of Colorado Cancer ...
MSK researchers found that BRCA2 mutations lower the barrier for RB1 loss, causing CDK4/6 inhibitor resistance.
Matthew Powell, MD, discusses long-term overall survival results with dostarlimab plus chemo in dMMR endometrial cancer ...
FDA orphan drug designation provides incentives including regulatory support, tax credits, fee exemptions, and seven years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results